Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
The Lm-LLO technology, using bioengineered live attenuated Listeria monocytogenes bacteria, is the only known cancer immunotherapy agent ...
Advaxis Announces FDA Acceptance of Its Investigational New Drug Application to Commence ... -MarketWatch
Cancer immunotherapy (the harnessing of the body's defence system to fight the patient's cancer, has emerged as one of the most exciting medical ...
Bernado Rapoport, an oncologist in Rosebank, Johannesburg, said immunotherapy was a completely different way of fighting cancer and offers "new ...
Dr David Liens, ImmunID's Chief Medical Officer, explained: "ImmunID is committed to help in the management of cancer immunotherapies.
The Role of Bisphosphonates in Early- and Advanced-Stage Breast Cancer: Have We Finally Optimized Care?
Bisphosphonates have played an important role in the treatment of breast cancer, mainly in patients with bone metastasis, by reducing the risk of fracture, spinal cord compression, and hypercalcemia.
Bisphosphonates have played an important role in the treatment of breast cancer, mainly in patients with bone metastasis, by reducing the risk of fracture, spinal cord compression, and hypercalcemia.
Commentaries
• Osteoclast Inhibitors: A Multifaceted Tool in the Management of Breast Cancer
• Bisphosphonates in Breast Cancer: A Triple Winner?
• Osteoclast Inhibitors: A Multifaceted Tool in the Management of Breast Cancer
• Bisphosphonates in Breast Cancer: A Triple Winner?
Cancer News in Science Daily
A new study pools data from 25 case-control studies and conducts separate analyses to show that head and neck cancers in young adults are more likely to be as a result of inherited factors, rather than lifestyle factors such as smoking or drinking alcohol.
The first major analysis based on the Human Protein Atlas has been published, including a detailed picture of the proteins that are linked to cancer, the number of proteins present in the bloodstream, and the targets for all approved drugs on the market.
Upending decades-old dogma, a team of scientists say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that current clinical efforts to develop inhibitor-based drugs should instead focus on restoring the enzymes’ activities.
New animal models that reproduce faithfully the evolution and malignancy of different human tumors have been developed by researchers. This facilitates parallel tumor progression in patients suffering from the disease in an animal laboratory mice in this case; and predict possible relapses and anticipate what will be most effective treatments.
Researchers report on the use of denoising autoencoders (DAs) to effectively extract key biological principles from gene expression data and summarize them into constructed features with convenient properties.
Long-term use of hormonal contraceptives is associated with an increased risk of a rare brain tumor, study finds
Taking a hormonal contraceptive for at least five years is associated with a possible increase in a young woman's risk of developing a rare tumor, glioma of the brain, according to a new study of women aged 15-49 years.
A major research study has uncovered several new genetic mutations that could drive testicular cancer -- and also identified a gene which may contribute to tumors becoming resistant to current treatments.
Melanoma, the most aggressive of all skin cancer strains, is often fatal for patients due to the pronounced formation of metastases. Until now, a melanoma's rampant growth was mainly attributed to genetic causes, such as mutations in certain genes. However, researchers now reveal that so-called epigenetic factors play a role in the formation of metastases in malignant skin cancer. This opens up new possibilities for future cancer treatments.
Tambahkan Komentar